ViroNovative BV is a spin-out company formed under the new active incubator policy of Erasmus University Rotterdam, The Netherlands, and dedicated to providing a complete solution to human Metapneumovirus (hMPV), a virus discovered in 2001 at the Erasmus Medical Center's Department of Virology. To this end, ViroNovative is developing diagnostics, vaccines and antivirals for the detection, prevention and treatment of hMPV infection. ViroNovative is a member of ViroVentures, a virtual organization whose members share certain resources and expertise to meet their common goal of improving human and animal health, through developing treatments and diagnostics to infectious diseases.
| Website | http://www.vironovative.com |
| Revenue | $6 million |
| Employees | View employees |
| Address | 16 Marconistraat, Rotterdam, NL |
| Fax | +31 320 264 828 |
| Industry | Business Services General, Business Services |
| Competitors | STEMCELL Technologies, Organogenesis, Mesoblast Limited, Pluristem Therapeutics, Athersys, Sernova Corp., Cynata Therapeutics, ReNeuron Group Plc, TiGenix, CELL MEDICA LIMITED +36 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular ViroNovative BV employee's phone or email?
ViroNovative BV Questions
The ViroNovative BV annual revenue was $6 million in 2026.
The NAICS codes for ViroNovative BV are [541713, 5417, 54171, 54, 541].
The SIC codes for ViroNovative BV are [87, 873].
